FDA has cleared an investigational new drug (IND) application to study switchable chimeric antigen receptor T cell (sCAR-T) therapy (CLBR001 + SWI019) in patients with autoimmune conditions. Patient ...

Researchers from Queen Mary University of London have developed an AI tool that creates synthetic yet medically accurate ...

Bullish option flow detected in Lam Research (LRCX) with 15,438 calls trading, 1.5x expected, and implied vol increasing over 11 points to ...

Wells Fargo & Company MN didn’t just dip a toe into Lam Research—they cannonballed in, boosting their stake by a whopping 836 ...

Scientists have helped identify a novel drug compound that selectively activates pain-altering receptors in the body, offering a potentially safer alternative to conventional pain medications.

Gadar 3 EXCLUSIVE: Sunny Deol says he ‘would love to play Tara Singh over and over again’; shares the reason behind it Did King helmer Siddharth Anand hint at reports of Deepika Padukone’s ...

The research by Neurology discovered women in their eighties who experience sleep disruption have an association with ...

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), ...

Lam Research Co. (NASDAQ:LRCX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the twenty-three ...

A population-based cohort study of more than three million adults assessed the association between changes in residential neighbourhood walkability and cardiovascular disease (CVD) incidence. Four ...

Lam Research (NASDAQ:LRCX – Get Free Report) had its price objective raised by research analysts at Jefferies Financial Group ...

In the preceding three months, 13 analysts have released ratings for Lam Research (NASDAQ:LRCX), presenting a wide array of perspectives from bullish to bearish. The following table provides a ...